Healthcare Law Blog

OCTOBER 17, 2023

As described in a previous update , the DEA proposed a rule in March 2023 to extend some flexibilities while making permanent certain scenarios in which a practitioner could prescribe controlled substances without a prior in-person evaluation. Sheppard Mullin will continue to monitor developments and provide updates as they arise.

Telemedicine 52

Telemedicine COVID-19 Health Services Administration Public Health 52

Hall Render

DECEMBER 30, 2022

Medicare payment policy changes established under the CMS CY 2023 Medicare Physician Fee Schedule (“MPFS”) Final Rule , issued on November 1, 2022, become effective January 1, 2023. Below is a high-level summary of significant changes established for 2023. Telehealth Services. Evaluation and Management (E/M) Visits.

Medicare 40

Medicare Medicare Licensing Health Services Administration 40

Hall Render

MAY 9, 2023

Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023). Hall Render blog posts and articles are intended for informational purposes only.

COVID-19 40

COVID-19 Telemedicine Health Services Administration Public Health 40

Healthcare Law Blog

JANUARY 6, 2023

On December 29, 2022 , President Biden signed the Consolidated Appropriations Act, 2023 (the “Act”). In addition to funding, the Act modifies certain telehealth provisions, expands and extends components of the Medicare and Medicaid programs, and supports initiatives within the behavioral health and substance use treatment spaces.

COVID-19 52

COVID-19 Medicaid Medicaid Medicare 52

Health Law Advisor

MARCH 7, 2023

Both the proposed rules related to telemedicine prescribing of Schedule III-V non-narcotic controlled substances, and the separate proposed rules related to telemedicine prescribing of buprenorphine, were published in the Federal Register on March 1, 2023. 21 U.S.C. § 802(17).

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

Bill of Health

NOVEMBER 15, 2023

These and other impediments are remnants of the “war on drugs” and are both the product of and the nourishment for moral defect judgments that perpetuate stigma against people with OUD. Code § 1701 et seq.

Governance 167

Governance Public Health Telemedicine Medicaid 167

Hall Render

DECEMBER 30, 2022

On December 2, 2022, the Department of Health and Human Services (“HHS”) Substance Abuse and Mental Health Services Administration (“SAMHSA”) released a proposed rule modifying the Confidentiality of Substance Use Disorder Patient Records regulations at 42 CFR Part 2 (“Part 2”). Your primary Hall Render contact.

HIPAA 75

HIPAA Health Services Administration Compliance Public Health 75